連続バイオプロセス市場：製品、エンドユーザー、用途別-2023-2030年の世界予測

連続バイオプロセスの世界市場は、2023年に111億5,824万米ドル、CAGR 12.85%で大きく成長し、2030年には260億5,722万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の連続バイオプロセス市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客ベース、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の発売、未開拓地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：ロシア・ウクライナ紛争、高インフレに関する包括的な理解を提供します。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.連続バイオプロセスの世界市場規模および予測は？

2.予測期間中、世界の連続バイオプロセス市場を形成するCOVID-19の阻害要因と影響は？

3.連続バイオプロセスの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.連続バイオプロセスの世界市場における競争戦略は？

5.連続バイオプロセスの世界市場における技術動向と規制の枠組みは？

6.連続バイオプロセスの世界市場における主要ベンダーの市場シェアは？

7.連続バイオプロセスの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • バイオ医薬品への需要の増大と業界に対する政府の支援
    • バッチ処理と使い捨てテクノロジーの導入に比べてメリットが増大
    • インダストリー4.0の到来と自動化とデジタル化への傾向
  • 抑制要因
    • 連続バイオプロセスに対する厳しい規制と高額な設備コスト
  • 機会
    • シングルユース機器に関連した灌流の採用
    • 間質細胞製造に対する連続バイオプロセスアプローチの開発
  • 課題
    • 運用上の困難とプロセスの変更に関する問題
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ
  • 自動化とロボットによるプロセスの統合

第6章 連続バイオプロセス市場：製品別

• バイオリアクター
• 細胞培養培地および試薬
• 遠心分離機
• クロマトグラフィーシステムと消耗品
• 濾過システムと消耗品
• インキュベーターとシェーカー
• 混合システム

第7章 連続バイオプロセス市場：エンドユーザー別

• 学術調査機関
• 受託開発・製造組織
• 製薬およびバイオテクノロジー企業

第8章 連続バイオプロセス市場：用途別

• 商業用
  • 細胞および遺伝子治療薬の製造
  • モノクローナル抗体の生産
  • 血漿分別
  • 組換えタンパク質の生産
  • ワクチン製造
• 研究開発

第9章 南北アメリカの連続バイオプロセス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の連続バイオプロセス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの連続バイオプロセス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. CONTINUOUS BIOPROCESSING MARKET RESEARCH PROCESS
• FIGURE 2. CONTINUOUS BIOPROCESSING MARKET SIZE, 2022 VS 2030
• FIGURE 3. CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 5. CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 6. CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 7. CONTINUOUS BIOPROCESSING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. CONTINUOUS BIOPROCESSING MARKET DYNAMICS
• FIGURE 9. CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. CONTINUOUS BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. CONTINUOUS BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. CONTINUOUS BIOPROCESSING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 5. CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL CULTURE MEDIA & REAGENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. CONTINUOUS BIOPROCESSING MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. CONTINUOUS BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEM & CONSUMABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. CONTINUOUS BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEMS AND CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. CONTINUOUS BIOPROCESSING MARKET SIZE, BY INCUBATORS & SHAKERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. CONTINUOUS BIOPROCESSING MARKET SIZE, BY MIXING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 13. CONTINUOUS BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 17. CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 18. CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL & GENE THERAPY PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. CONTINUOUS BIOPROCESSING MARKET SIZE, BY MONOCLONAL ANTIBODIES PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. CONTINUOUS BIOPROCESSING MARKET SIZE, BY PLASMA FRACTIONATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEIN PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINE MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. CONTINUOUS BIOPROCESSING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 38. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 60. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 64. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 133. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 149. POLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. POLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. POLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. POLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 153. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2030 (USD MILLION)
• TABLE 193. CONTINUOUS BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 194. CONTINUOUS BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 195. CONTINUOUS BIOPROCESSING MARKET LICENSE & PRICING

The Global Continuous Bioprocessing Market is forecasted to grow significantly, with a projected USD 11,158.24 million in 2023 at a CAGR of 12.85% and expected to reach a staggering USD 26,057.22 million by 2030.

The the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Continuous Bioprocessing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Continuous Bioprocessing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Bioreactors, Cell Culture Media & Reagent, Centrifuges, Chromatography System & Consumable, Filtration Systems and Consumables, Incubators & Shakers, and Mixing Systems. The Bioreactors commanded largest market share of 28.39% in 2022, followed by Cell Culture Media & Reagent.

Based on End-User, market is studied across Academic & Research Institutes, Contract Development & Manufacturing Organizations, and Pharmaceutical & Biotechnology Companies. The Pharmaceutical & Biotechnology Companies commanded largest market share of 59.91% in 2022, followed by Contract Development & Manufacturing Organizations.

Based on Application, market is studied across Commercial and Research & Development. The Commercial is further studied across Cell & Gene Therapy Production, Monoclonal Antibodies Production, Plasma Fractionation, Recombinant Protein Production, and Vaccine Manufacturing. The Commercial commanded largest market share of 84.65% in 2022, followed by Research & Development.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 39.47% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Continuous Bioprocessing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Continuous Bioprocessing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Continuous Bioprocessing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Continuous Bioprocessing Market?

4. What is the competitive strategic window for opportunities in the Global Continuous Bioprocessing Market?

5. What are the technology trends and regulatory frameworks in the Global Continuous Bioprocessing Market?

6. What is the market share of the leading vendors in the Global Continuous Bioprocessing Market?

7. What modes and strategic moves are considered suitable for entering the Global Continuous Bioprocessing Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Continuous Bioprocessing Market, by Product, 2022 vs 2030
• 4.3. Continuous Bioprocessing Market, by End-User, 2022 vs 2030
• 4.4. Continuous Bioprocessing Market, by Application, 2022 vs 2030
• 4.5. Continuous Bioprocessing Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing Demand for Biopharmaceuticals & Government Support for the Industry
    • 5.1.1.2. Increased Benefits over Batch Processing & Uptake of Single Use Technology
    • 5.1.1.3. Advent of Industry 4.0 & Trend Towards Automation & Digitization
  • 5.1.2. Restraints
    • 5.1.2.1. Strict Regulations for Continuous Bioprocessing Coupled with High Equipment Cost
  • 5.1.3. Opportunities
    • 5.1.3.1. Adoption of Perfusion Associated with Single-Use Equipment
    • 5.1.3.2. Development of a Continuous Bioprocessing Approach to Stromal Cell Manufacturing
  • 5.1.4. Challenges
    • 5.1.4.1. Issues with Operational Difficulties and Process Changes
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization
  • 5.9.1. Automation & Robotic Process Integration

6. Continuous Bioprocessing Market, by Product

• 6.1. Introduction
• 6.2. Bioreactors
• 6.3. Cell Culture Media & Reagent
• 6.4. Centrifuges
• 6.5. Chromatography System & Consumable
• 6.6. Filtration Systems and Consumables
• 6.7. Incubators & Shakers
• 6.8. Mixing Systems

7. Continuous Bioprocessing Market, by End-User

• 7.1. Introduction
• 7.2. Academic & Research Institutes
• 7.3. Contract Development & Manufacturing Organizations
• 7.4. Pharmaceutical & Biotechnology Companies

8. Continuous Bioprocessing Market, by Application

• 8.1. Introduction
• 8.2. Commercial
  • 8.2.1. Cell & Gene Therapy Production
  • 8.2.2. Monoclonal Antibodies Production
  • 8.2.3. Plasma Fractionation
  • 8.2.4. Recombinant Protein Production
  • 8.2.5. Vaccine Manufacturing
• 8.3. Research & Development

9. Americas Continuous Bioprocessing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Continuous Bioprocessing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Continuous Bioprocessing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

1. 3M Company

2. Applikon Biotechnology B.V.

3. Bio-Rad Laboratories, Inc.

4. Bionet

5. Colder Products Company

6. Danaher Corporation

7. Eppendorf AG

8. Fujifilm Holdings Corporation

9. GE Healthcare

10. Lonza Group

11. Merck KGaA

12. Repligen Corporation

13. Sartorius AG

14. Thermo Fisher Scientific Inc.

15. Watson-Marlow Fluid Technology Group

16. WuXi Biologics